Related references
Note: Only part of the references are listed.Increased NF-κB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer's disease
Chia-Hsiung Chen et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition
Paramita Chakrabarty et al.
MOLECULAR NEURODEGENERATION (2012)
NF-κB signaling inhibits ubiquitin carboxyl-terminal hydrolase L1 gene expression
Ruitao Wang et al.
JOURNAL OF NEUROCHEMISTRY (2011)
GSK-3α/β kinases and amyloid production in vivo
Tomasz Jaworski et al.
NATURE (2011)
Aβ1-42 inhibition of LTP is mediated by a signaling pathway involving caspase-3, Akt1 and GSK-3β
Jihoon Jo et al.
NATURE NEUROSCIENCE (2011)
GSK-3: functional insights from cell biology and animal models
Oksana Kaidanovich-Beilin et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
Massive gliosis induced by interleukin-6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition
Paramita Chakrabarty et al.
FASEB JOURNAL (2010)
BACE1 Gene Promoter Single-Nucleotide Polymorphisms in Alzheimer's Disease
Weihui Zhou et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2010)
Neuroinflammation - An Early Event in Both the History and Pathogenesis of Alzheimer's Disease
Piet Eikelenboom et al.
NEURODEGENERATIVE DISEASES (2010)
Powerful beneficial effects of macrophage colony-stimulating factor on -amyloid deposition and cognitive impairment in Alzheimers disease
Vincent Boissonneault et al.
BRAIN (2009)
Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity
Christopher J. Yuskaitis et al.
CELLULAR SIGNALLING (2009)
Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain
Eleonore Beurel et al.
JOURNAL OF NEUROINFLAMMATION (2009)
Differential regulation of STAT family members by glycogen synthase kinase-3
Eleonore Beurel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
NFκB-dependent control of BACE1 promoter transactivation by Aβ42
Virginie Buggia-Prevot et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Valproic acid inhibits Aβ production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models
Hong Qing et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of β-site amyloid precursor protein-cleaving enzyme 1
Wang-Xia Wang et al.
JOURNAL OF NEUROSCIENCE (2008)
Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease
Marc Aurel Busche et al.
SCIENCE (2008)
Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice
Lisa McConlogue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology
Solomon S. Shaftel et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
GSK3β activity modifies the localization and function of presenilin 1
Kengo Uemura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Differential regulation of BACE1 promoter activity by nuclear factor-κB in neurons and glia upon exposure to β-amyloid peptides
Krystyn Z. Bourne et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
β-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques:: Implications for Alzheimer's disease pathogenesis
Jie Zhao et al.
JOURNAL OF NEUROSCIENCE (2007)
Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases β-cleavage of amyloid precursor protein and amyloid-β production in vivo
Ishrut Hussain et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression
Xiulian Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Bace1 modulates myelination in the central and peripheral nervous system
Xiangyou Hu et al.
NATURE NEUROSCIENCE (2006)
Control of peripheral nerve myelination by the β-secretase BACE1
Michael Willem et al.
SCIENCE (2006)
Increased BACE1 maturation contributes to the pathogenesis of Alzheimer's disease in Down syndrome
Xiulian Sun et al.
FASEB JOURNAL (2006)
BACE2, as a novel APP θ-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome
Xiulian Sun et al.
FASEB JOURNAL (2006)
Leaky scanning and reinitiation regulate BACE1 gene expression
WH Zhou et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Control of APP processing and Aβ generation level by BACE1 enzymatic activity and transcription
Yu Li et al.
FASEB JOURNAL (2006)
Glycogen synthase kinase 3β functions to specify gene-specific, NF-κB-dependent transcription
KA Steinbrecher et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo
W Noble et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The low density lipoprotein receptor-related protein (LRP) is a novel β-secretase (BACE1) substrate
CAF von Arnim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes
XL Sun et al.
FASEB JOURNAL (2005)
BACE (β-secretase) modulates the processing of APLP2 in vivo
L Pastorino et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2004)
Cleavage of amyloid-β precursor protein and amyloid-β precursor-like protein by BACE 1
QM Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Differential utilization of upstream AUGs in the β-secretase mRNA suggests that a shunting mechanism regulates translation
GW Rogers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Translational regulation of BACE-1 expression in neuronal and non-neuronal cells
DD Tonelli et al.
NUCLEIC ACIDS RESEARCH (2004)
β-secretase activity increases with aging in human, monkey, and mouse brain
H Fukumoto et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
BACE1 suppression by RNA interference in primary cortical neurons
SC Kao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease
M Ohno et al.
NEURON (2004)
Genetic deletion of glycogen synthase kinase-3β abrogates activation of IκBα kinase, JNK, Akt, and p44/p42 MAPK but potentiates apoptosis induced by tumor necrosis factor
Y Takada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis
MC Herzig et al.
NATURE NEUROSCIENCE (2004)
Glycogen synthase kinase 3β induces caspase-cleaved tau aggregation in situ
JH Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Lithium, a common drug for bipolar disorder treatment, regulates amyloid-β precursor protein processing
Y Su et al.
BIOCHEMISTRY (2004)
The 1239G/C polymorphism in exon 5 of BACE1 gene may be associated with sporadic Alzheimer's disease in Chinese Hans
JJ Shi et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2004)
Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1
MA Christensen et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Expression of the Alzheimer protease BACE1 is suppressed via its 5′-untranslated region
S Lammich et al.
EMBO REPORTS (2004)
Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review
CA Szekely et al.
NEUROEPIDEMIOLOGY (2004)
Demonstration of BACE (β-secretase) phosphorylation and its interaction with GGA1 in cells by fluorescence-lifetime imaging microscopy
CAF von Arnim et al.
JOURNAL OF CELL SCIENCE (2004)
GSK3 inhibitors: Development and therapeutic potential
P Cohen et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
The Mood-Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase-3
Guang Chen et al.
JOURNAL OF NEUROCHEMISTRY (2003)
The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1
SF Lichtenthaler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418
R Bhat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Association study between Alzheimer's disease and genes involved in Aβ biosynthesis, aggregation and degradation:: suggestive results with BACE1
J Clarimón et al.
JOURNAL OF NEUROLOGY (2003)
Polymorphism in the BACE gene influences the risk for Alzheimer's disease
CM Kirschling et al.
NEUROREPORT (2003)
GSK-3α regulates production of Alzheimer's disease amyloid-β peptides
CJ Phiel et al.
NATURE (2003)
GSK-3: tricks of the trade for a multi-tasking kinase
BW Doble et al.
JOURNAL OF CELL SCIENCE (2003)
Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease
LB Yang et al.
NATURE MEDICINE (2003)
Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium
P De Sarno et al.
NEUROPHARMACOLOGY (2002)
Scaffold hopping and optimization towards libraries of glycogen synthase kinase-3 inhibitors
L Nærum et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
Increased expression of the amyloid precursor β-secretase in Alzheimer's disease
RMD Holsinger et al.
ANNALS OF NEUROLOGY (2002)
Alzheimer's β-secretase, β-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase
S Kitazume et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Amyloid β secretase gene (BACE) is neither mutated in nor associated with early-onset Alzheimer's disease
M Cruts et al.
NEUROSCIENCE LETTERS (2001)
BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain:: implications for Alzheimer's disease therapeutics
SL Roberds et al.
HUMAN MOLECULAR GENETICS (2001)
Phosphorylation regulates intracellular trafficking of β-secretase
J Walter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease
Y Matsuoka et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death
DAE Cross et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation
Y Luo et al.
NATURE NEUROSCIENCE (2001)
BACE1 is the major β-secretase for generation of Aβ peptides by neurons
HB Cai et al.
NATURE NEUROSCIENCE (2001)
Glycogen synthase kinase-3β phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice
K Spittaels et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
ASP1 (BACE2) cleaves the amyloid precursor protein at the β-secretase site
I Hussain et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2000)
Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription
MP Coghlan et al.
CHEMISTRY & BIOLOGY (2000)
Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
KP Hoeflich et al.
NATURE (2000)
Wnt signaling to β-catenin involves two interactive components -: Glycogen synthase kinase-3β inhibition and activation of protein kinase C
RH Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Neurobiology - Presenilin-1 mutations in Alzheimer's disease
C Russo et al.
NATURE (2000)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
Share Paper
